NEW YORK, Jan. 24 - Estonian genotyping company Asper Biotech will use Orchid BioSciences' SNP-IT technology in a new slide-based array product aimed at bioscience research, the companies said on Thursday.
Under the deal, which is arranged as a non-exclusive license, Orchid will receive an upfront payment and royalties on sales. The companies did not disclose details.
SNP-IT is Orchid's primer extension SNP scoring technology. Asper's system, called Genorama, is a four-color SNP scoring device for medium-throughput genotyping.
Asper Biotech is a privately held biotech firm founded in 1999 in Tartu, Estonia. Last summer it launched a p53 gene-sequencing and mutation-detection bioarray chip. It is also involved with the Estonian government and Gene Bank project in efforts to establish a population genetics database.